We are live on
!
Find out more
Iovance Biotherapeutics
IOVA
IOVA
269 hedge funds and large institutions have $6.9B invested in Iovance Biotherapeutics in 2020 Q4 according to their latest regulatory filings, with 57 funds opening new positions, 86 increasing their positions, 97 reducing their positions, and 39 closing their positions.
New
Increased
Maintained
Reduced
Closed
54% more call options, than puts
Call options by funds: $120M | Put options by funds: $77.8M
51% more capital invested
Capital invested by funds: $4.58B → $6.9B (+$2.32B)
46% more first-time investments, than exits
New positions opened: 57 | Existing positions closed: 39
22% more funds holding in top 10
Funds holding in top 10: 9 → 11 (+2)
7% more funds holding
Funds holding: 252 → 269 (+17)
5.83% more ownership
Funds ownership: 95.58% → 101.41% (+5.8%)
11% less repeat investments, than reductions
Existing positions increased: 86 | Existing positions reduced: 97
Holders
269
Holders Change
+17
Holders Change %
+6.75%
% of All Funds
4.76%
Holding in Top 10
11
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+22.22%
% of All Funds
0.19%
New
57
Increased
86
Reduced
97
Closed
39
Calls
$120M
Puts
$77.8M
Net Calls
+$42M
Net Calls Change
+$15.8M
Top Buyers
Top Sellers
| 1 |
GPP
Great Point Partners
Greenwich,
Connecticut
|
-$117M |
| 2 |
ACA
Avoro Capital Advisors
New York
|
-$80.8M |
| 3 |
PA
Perceptive Advisors
New York
|
-$36.5M |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
-$29.4M |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$27.1M |
